Fibrosis progresses more rapidly to cirrhosis in patients with HCV, IR, and T2DM, except for HCV genotype 3, which is less responsive to treatment with interferon (IFN)14, 15. Here, IFNA1 is linked to type 2 diabetes mellitus.